Vertex Pharmaceuticals (VRTX): are the analysts right?

Vertex Pharmaceuticals · Health Care · ref. ETF XLV · 103 calls · price $522.25
What the company does: Vertex Pharmaceuticals développe des médicaments biotechnologiques pour maladies graves comme fibrose kystique et drépanocytose.
📈 1-year price
$522.25+12.0% over range
Jul 8, 25low $366.54 · high $529.59Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
76% recommend buying · 17 analysts

🎯 Analyst price target on VRTX

High target · 1 analyst$641+22.7%
Median target · 16 analysts$573.5+9.8%
Low target · 1 analyst$350-33.0%
Current price$522.25

🗳️ The analyst consensus

Analyst breakdown · 17 (6 months)
Strong Buy0%
Buy76%
Hold18%
Sell6%
Strong Sell0%

✅ Historical analyst reliability on VRTX

Most reliable analysts on VRTX (% profitable · 365j · ≥2 calls)
UBS 83% +17.2% 12
Bernstein 80% +23.7% 5
HC Wainwright & Co. 80% +14.3% 15
Argus Research 57% +11.0% 7
Cantor Fitzgerald 50% +0.1% 12

📊 What $1,000 invested in Vertex Pharmaceuticals would be worth

In short — $1,000 invested in Vertex Pharmaceuticals 10 years ago would be worth $3,948 today, i.e. +15%/yr on average. Best year: 2017 (+103%), worst: 2016 (-41%). Price performance, excluding dividends.

If I'd invested $1,000 in Vertex Pharmaceuticals

InvestmentWorth todayGain
1 years ago$1,233+23%
3 years ago$1,720+72%
5 years ago$2,102+110%
10 years ago$3,948+295%
since inception (1991)$95,755+9476%

Return by year (Vertex Pharmaceuticals)

YearReturn$1,000 invested at year start
2026 (YTD)+10%$1,096 (+10%)
2025+13%$1,233 (+23%)
2024-1%$1,221 (+22%)
2023+41%$1,720 (+72%)
2022+32%$2,262 (+126%)
2021-7%$2,102 (+110%)
2020+8%$2,269 (+127%)
2019+32%$2,998 (+200%)
2018+11%$3,315 (+231%)
2017+103%$6,743 (+574%)
2016-41%$3,948 (+295%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on VRTX

RBC Capital
Jul 7, 26
▲ Outperform · 🎯$570
Today : $522.25 — upside +9%
🎯 on VRTX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jul 7, 27
Baird
Jul 7, 26
▼ Underperform · 🎯$350
Price at call : $522.25 — upside -33%
Today : $522.25 — upside -33%
🎯 on VRTX : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jul 7, 27
Barclays
May 6, 26
▲ Overweight · 🎯$615
Price at call : $425 — upside +45%
Today : $522.25 — upside +18%
🎯 on VRTX : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 6, 27
■ Hold neutral · not a buy · 🎯$436
Price at call : $427.65 — gap to target +2%
Today : $522.25 — gap to target -17%
🎯 on VRTX : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : May 5, 27
▲ Overweight · 🎯$616
Price at call : $427.65 — upside +44%
Today : $522.25 — upside +18%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : May 5, 27
Bernstein
May 5, 26
▲ Outperform · 🎯$572
Price at call : $427.65 — upside +34%
Today : $522.25 — upside +10%
🎯 on VRTX : 80% (5 calls matureds) · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : May 5, 27
RBC Capital
May 5, 26
▲ Outperform · 🎯$543
Price at call : $427.65 — upside +27%
Today : $522.25 — upside +4%
🎯 on VRTX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : May 5, 27
■ Hold neutral · not a buy · 🎯$437
Price at call : $423.92 — gap to target +3%
Today : $522.25 — gap to target -16%
🎯 on VRTX : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : May 1, 27
▲ Overweight · 🎯$612
Price at call : $440.05 — upside +39%
Today : $522.25 — upside +17%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 10, 27
Maxim Group
Mar 18, 26
▲ Buy · 🎯$575
Price at call : $458.05 — upside +26%
Today : $522.25 — upside +10%
🎯 on VRTX : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Mar 18, 27
▲ Buy · 🎯$525
Price at call : $478.13 — upside +10%
Today : $522.25 — upside +1%
🎯 on VRTX : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Mar 11, 27
▲ Overweight · 🎯$596
Price at call : $492.38 — upside +21%
Today : $522.25 — upside +14%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Mar 10, 27
▲ Buy · 🎯$598
Price at call : $492.38 — upside +21%
Today : $522.25 — upside +15%
🎯 on VRTX : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Mar 10, 27
Citigroup
Mar 10, 26
▲ Buy · 🎯$585
Price at call : $492.38 — upside +19%
Today : $522.25 — upside +12%
🎯 on VRTX : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 10, 27
Oppenheimer
Mar 10, 26
▲ Outperform · 🎯$600
Price at call : $492.38 — upside +22%
Today : $522.25 — upside +15%
🎯 on VRTX : no call matured yet · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Mar 10, 27
Jefferies
Mar 10, 26
▲ Buy · 🎯$580
Price at call : $492.38 — upside +18%
Today : $522.25 — upside +11%
🎯 on VRTX : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Mar 10, 27
▲ Buy · 🎯$641
Price at call : $499.17 — upside +28%
Today : $522.25 — upside +23%
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Mar 10, 27
■ Hold neutral · not a buy · 🎯$441
Price at call : $470.31 — gap to target -6%
Today : $522.25 — gap to target -16%
🎯 on VRTX : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Feb 17, 27
Barclays
Feb 17, 26
▲ Overweight · 🎯$607
Price at call : $470.31 — upside +29%
Today : $522.25 — upside +16%
🎯 on VRTX : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 17, 27
▲ Buy · 🎯$591
Price at call : $477.32 — upside +24%
Today : $522.25 — upside +13%
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Feb 17, 27
Scotiabank
Feb 13, 26
■ Sector Perform neutral · not a buy · 🎯$558
Price at call : $477.32 — gap to target +17%
Today : $522.25 — gap to target +7%
🎯 on VRTX : no call matured yet · 📊 on Health : 16.7% · -12.6% (6 calls)
in progress (365j)
matures : Feb 13, 27
RBC Capital
Feb 13, 26
▲ Outperform · 🎯$541
Price at call : $477.32 — upside +13%
Today : $522.25 — upside +4%
🎯 on VRTX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 13, 27
Stifel
Feb 13, 26
■ Hold neutral · not a buy · 🎯$466
Price at call : $477.32 — gap to target -2%
Today : $522.25 — gap to target -11%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 13, 27
Oppenheimer
Feb 13, 26
▲ Outperform · 🎯$540
Price at call : $477.32 — upside +13%
Today : $522.25 — upside +3%
🎯 on VRTX : no call matured yet · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Feb 13, 27
▲ Buy · 🎯$518
Price at call : $491.47 — upside +5%
Today : $522.25 — upside -1%
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Feb 13, 27
Barclays
Jan 28, 26
▲ Overweight · 🎯$606
Price at call : $475.68 — upside +27%
Today : $522.25 — upside +16%
🎯 on VRTX : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jan 28, 27
UBS
Jan 26, 26
▲ Buy · 🎯$545
Price at call : $474.17 — upside +15%
Today : $522.25 — upside +4%
🎯 on VRTX : 83% (12 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jan 26, 27
▲ Outperform · 🎯$530
Price at call : $468.41 — upside +13%
Today : $522.25 — upside +1%
🎯 on VRTX : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jan 23, 27
RBC Capital
Jan 22, 26
▲ Outperform · 🎯$546
Price at call : $468.41 — upside +17%
Today : $522.25 — upside +5%
🎯 on VRTX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jan 22, 27
Bernstein
Jan 12, 26
▲ Outperform
🎯 on VRTX : 80% (5 calls matureds) · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : Jan 12, 27
▲ Outperform · 🎯$548
Price at call : $468.38 — upside +17%
Today : $522.25 — upside +5%
🎯 on VRTX : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Jan 6, 27
▲ Outperform · 🎯$525
Price at call : $459.78 — upside +14%
Today : $522.25 — upside +1%
🎯 on VRTX : no call matured yet · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : Dec 29, 26
Wells Fargo
Dec 10, 25
▲ Overweight · 🎯$515
Price at call : $445.93 — upside +15%
Today : $522.25 — upside -1%
🎯 on VRTX : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 10, 26
▲ Overweight · 🎯$564
Price at call : $442.04 — upside +28%
Today : $522.25 — upside +8%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 5, 26
▲ Overweight · 🎯$516
Price at call : $457.36 — upside +13%
Today : $522.25 — upside -1%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 3, 26
UBS
Nov 7, 25
▲ Buy · 🎯$546
Price at call : $421.2 — upside +30%
Today : $522.25 — upside +5%
🎯 on VRTX : 83% (12 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 7, 26
RBC Capital
Nov 4, 25
■ Sector Perform neutral · not a buy · 🎯$415
Price at call : $417 — gap to target -0%
Today : $522.25 — gap to target -21%
🎯 on VRTX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Nov 4, 26
Barclays
Nov 4, 25
■ Equal-Weight neutral · not a buy · 🎯$414
Price at call : $421.67 — gap to target -2%
Today : $522.25 — gap to target -21%
🎯 on VRTX : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Nov 4, 26
Stifel
Nov 4, 25
■ Hold neutral · not a buy · 🎯$445
Price at call : $421.67 — gap to target +6%
Today : $522.25 — gap to target -15%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Nov 4, 26
■ Equal-Weight neutral · not a buy · 🎯$438
Price at call : $407.37 — gap to target +8%
Today : $522.25 — gap to target -16%
🎯 on VRTX : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 10, 26
JP Morgan
Oct 8, 25
▲ Overweight · 🎯$530
Price at call : $414.86 — upside +28%
Today : $522.25 — upside +1%
🎯 on VRTX : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Oct 8, 26
Citigroup
Oct 2, 25
▲ Buy · 🎯$575
Price at call : $403.3 — upside +43%
Today : $522.25 — upside +10%
🎯 on VRTX : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Oct 2, 26
▲ Outperform · 🎯$456
Price at call : $381.87 — upside +19%
Today : $522.25 — upside -13%
🎯 on VRTX : no call matured yet · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : Sep 25, 26
▲ Outperform · 🎯$475
Price at call : $394.53 — upside +20%
Today : $522.25 — upside -9%
🎯 on VRTX : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Sep 11, 26
■ Market Perform neutral · not a buy
🎯 on VRTX : no call matured yet · 📊 on Health : 46.8% · +2.0% (395 calls)
in progress (365j)
matures : Sep 3, 26
Citigroup
Aug 7, 25
▲ Buy · 🎯$550
Price at call : $366.54 — upside +50%
Today : $522.25 — upside +5%
🎯 on VRTX : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Aug 7, 26
■ Hold neutral · not a buy · 🎯$411
Price at call : $375.63 — gap to target +9%
Today : $522.25 — gap to target -21%
🎯 on VRTX : no call matured yet · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Aug 6, 26
Guggenheim
Aug 6, 25
▲ Buy · 🎯$546
Price at call : $375.63 — upside +45%
Today : $522.25 — upside +5%
🎯 on VRTX : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Aug 6, 26
Wells Fargo
Aug 6, 25
▲ Overweight · 🎯$460
Price at call : $385.65 — upside +19%
Today : $522.25 — upside -12%
🎯 on VRTX : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 6, 26
▲ Buy · 🎯$490
Price at call : $385.65 — upside +27%
Today : $522.25 — upside -6%
🎯 on VRTX : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Aug 5, 26
▲ Buy · 🎯$478
Price at call : $374.98 — upside +27%
Today : $522.25 — upside -8%
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Aug 5, 26
▲ Buy · 🎯$550
Price at call : $443.54 — upside +24%
Today : $522.25 — upside +5%
Expected +24% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
+5.6%
stock +6% · XLV +15%
▲ Overweight · 🎯$535
Price at call : $450.03 — upside +19%
Today : $522.25 — upside +2%
Expected +19% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 50% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-5.0%
stock -5% · XLV +8%
■ Market Perform neutral · not a buy · 🎯$503
Price at call : $450.03 — gap to target +12%
Today : $522.25 — gap to target -4%
🎯 on VRTX : no call matured yet · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : May 6, 26
UBS
Feb 11, 25
▲ Buy · 🎯$583
Price at call : $453.2 — upside +29%
Today : $522.25 — upside +12%
Expected +29% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 83% (12 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+2.6%
stock +3% · XLV +7%
▲ Overweight · 🎯$480
Price at call : $453.2 — upside +6%
Today : $522.25 — upside -8%
Expected +6% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 50% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
+2.6%
stock +3% · XLV +7%
▲ Buy · 🎯$550
Price at call : $455.22 — upside +21%
Today : $522.25 — upside +5%
Expected +21% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
+1.3%
stock +1% · XLV +7%
▲ Overweight · 🎯$480
Price at call : $470.37 — upside +2%
Today : $522.25 — upside -8%
Expected +2% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 50% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
+0.4%
stock +0% · XLV +6%
▲ Buy · 🎯$550
Price at call : $461.68 — upside +19%
Today : $522.25 — upside +5%
Expected +19% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 80% (15 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
+2.2%
stock +2% · XLV +6%
▲ Overweight · 🎯$480
Price at call : $443.88 — upside +8%
Today : $522.25 — upside -8%
Expected +8% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on VRTX : 50% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
+7.4%
stock +7% · XLV +7%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)